by Jordana Choucair | Oct 18, 2022 | Public Health/Prevention
A report from the House Select Subcommittee on the Coronavirus Crisis found that Trump political appointees and former White House officials interfered with Centers for Disease Control and Prevention (CDC) guidance and “bullied” officials. The report demonstrated a...
by Jordana Choucair | Oct 17, 2022 | Life Sciences
Starting today, Americans will be able to buy lower-cost hearing aids without a prescription or medical exam. The White House said that Walgreens Boots Alliance Inc. and Walmart Inc. locations are stocked with lower-cost hearing aids, while CVS Health Corp. will begin...
by Jordana Choucair | Oct 17, 2022 | Opioid/Substance Use Disorders
Senior Director Tym Rourke was interviewed for a HuffPost article about the availability and use of Narcan in New Hampshire. The article was written in response to a political candidate’s comments that that the treatment, which is used to stop the symptoms of an...
by Jordana Choucair | Oct 17, 2022 | Payers
A new Commonwealth Fund study shows that seniors who select Medicare Advantage (MA) over traditional Medicare plans this enrollment season will do so because of the perks. Overall, enrollment in MA plans is projected to rise to more than 50 percent by 2025....
by Jordana Choucair | Oct 17, 2022 | Payers
UnitedHealth Group’s Chief Financial Officer John Rex said it will cost the insurer $100 million to integrate Change Healthcare’s claims processing with its OptumInsight revenue cycle management unit. According to Rex, Change Healthcare will bring in a projected $800...
by Jordana Choucair | Oct 14, 2022 | D.C. News
The Biden administration extended the nation’s COVID-19 public health emergency for the next 90 days. Even though daily deaths and case rates have been falling, health officials are bracing for a potential surge of infections over the winter. The extension ensures...
Recent Comments